Lingxian pill for treating gout and preparation method of pill

Abstract

The invention discloses a Lingxian pill for treating gout and a preparation method of the pill. The Lingxian pill is mainly prepared from the following crude medicines in parts by weight: 130-150 parts of radix clematidis, 130-150 parts of glabrous greenbrier rhizome, 130-150 parts of dioscorea hypoglauca palibin, 130-150 parts of coix seed, 40-50 parts of stir-baked semen persicae, 40-50 parts of safflower, 40-50 parts of herba lycopi, 40-50 parts of semen plantaginis, 40-50 parts of rhizome of Chinese atractylodes, 40-50 parts of rhizoma alismatis, 40-50 parts of pseudobulbus cremastrae seu pleiones, 40-50 parts of polygonum cuspidatum, 40-50 parts of Indian damnacanthus herb, 20-40 parts of liquorice root and 40-50 parts of cortex phellodendri. The Lingxian pill disclosed by the invention, in treating gout, is free from toxic and side effects and is significant in treatment effect, and the total effective rate of the pill reaches 95.7%. Through clinical application for years, the Lingxian pill disclosed by the invention brings about good social and economic benefits, and the Longxian pill is capable of solving repeated attack of arthritis caused by gout and the pain of patients of hyperuricemia.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicines, in particular to a Lingxian pill for treating gout and a preparation method thereof. Background technique [0002] Gout is a metabolic disease caused by purine metabolism disorder, which has a high incidence rate, is difficult to cure, and has recurrent attacks. Gout mostly occurs in middle-aged and elderly people, obese people and mental workers. Its clinical features are hyperuricemia and the resulting gouty acute arthritis recurrent attack, tophi deposition, tophi chronic arthritis and joint deformity, etc. The main clinical manifestations are red and swollen joints, hot pain, recurrent attacks, and joint inflexibility. Often involves the kidneys causing chronic interstitial nephritis and uric acid nephrolithiasis. According to the cause of increased uric acid in the blood, it can be divided into two categories: primary and secondary. The cause of primary gout is due t...

AI Technical Summary

Problems solved by technology

However, there are also many Chinese patent medicines for the treatment of gout in the market, and there is a relative shortage of better curative effects. Patients still have to rely on a large number of Western medicines with relatively large toxic and side effects to stabilize their condition.